Long-term safety and efficacy of enzyme replacement therapy for Fabry disease (Q24533551)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15154115%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

title

Long-term safety and efficacy of enzyme replacement therapy for Fabry disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15154115%20AND%20SRC:MED&resulttype=core&format=json

enzyme replacement therapy

28 December 2019

main subject

0 references

1 reference

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15154115%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

7

Robert J Desnick

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15154115%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

author name string

William R Wilcox

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15154115%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Maryam Banikazemi

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15154115%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Nathalie Guffon

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15154115%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Stephen Waldek

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15154115%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Philip Lee

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15154115%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Gabor E Linthorst

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15154115%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

International Fabry Disease Study Group

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15154115%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

language of work or name

English

0 references

publication date

20 May 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15154115%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Human Genetics

28 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15154115%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

volume

75

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15154115%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15154115%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

page(s)

65-74

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15154115%20AND%20SRC:MED&resulttype=core&format=json

A phase 1/2 clinical trial of enzyme replacement in fabry disease: pharmacokinetic, substrate clearance, and safety studies

28 December 2019

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1182009

Fabry disease, an under-recognized multisystemic disorder: expert recommendations for diagnosis, management, and enzyme replacement therapy

24 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1182009

Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 98 hemizygous males

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1182009

Safety and efficacy of recombinant human alpha-galactosidase A replacement therapy in Fabry's disease

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1182009

Infusion of alpha-galactosidase A reduces tissue globotriaosylceramide storage in patients with Fabry disease

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1182009

Angiokeratoma corporis diffusum--Fabry's disease

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1182009

Improvement of cardiac function during enzyme replacement therapy in patients with Fabry disease: a prospective strain rate imaging study

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1182009

Clinical benefit in Fabry patients given enzyme replacement therapy--a case series.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1182009

Enzyme replacement therapy in Anderson-Fabry's disease: beneficial clinical effect on vital organ function

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1182009

Globotriaosylceramide accumulation in the Fabry kidney is cleared from multiple cell types after enzyme replacement therapy

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1182009

Natural history of Fabry renal disease: influence of alpha-galactosidase A activity and genetic mutations on clinical course

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1182009

Patients with Fabry disease on dialysis in the United States

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1182009

The short-form McGill Pain Questionnaire

29 November 2018

1 reference

12 December 2020

PR interval and the response to enzyme-replacement therapy for Fabry's disease

1 reference

12 December 2020

Antibody response in patients with Gaucher disease after repeated infusion with macrophage-targeted glucocerebrosidase

1 reference

12 December 2020

Quantitative determination of globotriaosylceramide by immunodetection of glycolipid-bound recombinant verotoxin B subunit

1 reference

12 December 2020

Immunosurveillance of alglucerase enzyme therapy for Gaucher patients: induction of humoral tolerance in seroconverted patients after repeat administration

1 reference

12 December 2020

Identifiers

DOI

10.1086/422366

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15154115%20AND%20SRC:MED&resulttype=core&format=json

release_32rq2dkjxrevzoa4htdkxetzeq

28 December 2019

Fatcat ID

0 references

OpenCitations bibliographic resource ID

4068494

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15154115%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

1 reference